Major depressive disorder (MDD) is becoming one of the most prevalent and proliferating public health concerns worldwide because of its high rate of morbidity, recurrence, and associated suicide, all of which result in a profound burden to both the individual and society. Clinical pharmacists face the everyday challenge of providing individualized, safe, and effective care for patients with MDD.
Through two interactive modules, this activity will review recent clinical data and guidelines in the management of MDD. Case studies will introduce potential treatment strategies, communication tools, and other data for learners to consider. This complimentary, application-based course consists of two modules (each valued at 1.0 contact hours of ACPE credit) authored by psychiatric pharmacists on the following topics:
Module 1: The Pathogenesis of Depression: From Traditional Theories to Novel Concepts (Matthew Fuller, PharmD, BCPS, BCPP, FASHP and Roger Sommi, PharmD, FCCP, BCPP)
Module 2: Treatment Selection in Depression: The Role of Pharmacists in Optimizing Therapeutic Outcomes (Patrick Finley, PharmD, BCPP and Amy Werremeyer, PharmD, BCPP)
There is no fee for the activity and participants must successfully complete an exam and evaluation at the end of each module in order to receive 2.0 contact hours (0.20 CEUs) of continuing pharmacy education credit. Take advantage of this great opportunity now!